Introduction
============

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in late December 2019. Since then, it has rapidly spread across the world, and was finally declared as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization on January 30^th^, 2020 \[[@b1-ophrp-2020-11-3-101]\].

SARS-CoV-2 is taxonomically classified under *Nidovirales* order, *Coronaviridae* family, *Coronavirinae* subfamily, and *betacornoavirus* genus. It is an enveloped virus with non-segmented, positive-sense, single-stranded RNA. Although SARS-CoV-2 presents with a lower pathogenicity than severe acute respiratory syndrome coronavirus (SARS-CoV) which emerged in 2002--2003, and Middle-East respiratory syndrome coronavirus (MERS-CoV) which emerged in 2012, it reveals more rapidly human-to-human transmission \[[@b2-ophrp-2020-11-3-101]\].

The genome of SARS-CoV-2 consists of non-segmented RNA that includes a 5′ untranslated region (UTR), structural proteins, non-structural proteins, several accessory proteins (open reading frames), and a 3′ UTR. The ORF1ab of several ORFs is proteolytically cleaved into 16 putative non-structural proteins (nsp1--16) for genome maintenance and replicase complex formation in viral replication. The structural proteins essential in viral particles include the spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins. The receptor-binding domain (RBD) of the S protein is crucial for binding directly to the human receptor ACE2, inducing viral entry, and determining host tropism and transmission capacity \[[@b3-ophrp-2020-11-3-101]--[@b5-ophrp-2020-11-3-101]\]. The S protein is cleaved into 2 subunits (S1 and S2). The S1 subunit directly recognizes and attaches to human receptor ACE2, while S2 fuses the host cell membrane with viral membranes allowing entry of SARS-CoV-2 \[[@b6-ophrp-2020-11-3-101]\]. In general, RNA viruses like SARS-CoV-2 undergo rapid mutation, enabling evolutionary and genetic diversity which result in alterations such as viral transmissibility, receptor affinity, host tropism, and pathogenicity.

In recent years, several studies based on mutation analysis of SARS-CoV-2 genome have attempted to understand phylogenetic relationships, host infectivity, human-to-human transmission, viral tropism, and pathogenicity of SARS-CoV in humans. Firstly, the comparative evolutionary diversity in point mutations (synonymous-non-synonymous mutations) are suggestive that SARS-CoV-2 should to be classified into 3 major clades (S, G, and V) and other clades according to amino acid changes \[[@b7-ophrp-2020-11-3-101]--[@b9-ophrp-2020-11-3-101]\]. Secondly, the high affinity and stable structure of RBD/ACE2 have been associated with amino acid variations in the RBD such as the high affinity group (N354D, D364Y, V367F, and W436R) \[[@b10-ophrp-2020-11-3-101]\], and the high ACE2-binding affinity and stability group (484-NGVEGFN-490, Q496N, and Q496Y) \[[@b11-ophrp-2020-11-3-101]\]. Thirdly, the deletion of 382 nucleotides towards the 3′ end of the viral genome may have an impact on viral phenotype \[[@b12-ophrp-2020-11-3-101]\], and the QTQTN motif adjacent to the polybasic cleavage site (RRAR, chain of amino acids) at the bridge between S1 and S2 may be related to host adaptation \[[@b13-ophrp-2020-11-3-101]\]. In addition, insertion of the RRAR which has been well known to determine high or low pathogenicity in avian influenza virus may be important in determining transmissibility and pathogenesis of SARS-CoV-2 \[[@b14-ophrp-2020-11-3-101]\]. Finally, primer-template mismatch has been known to affect the stability and functionality of polymerase. In particular, the primer-template mismatch located in the primer 3′ end region can interfere with polymerase active sites, and this may have a significant impact on the accuracy of the molecular diagnosis using primers or probes \[[@b15-ophrp-2020-11-3-101]\].

Therefore, we analyzed the mutations of the SARS-CoV-2 genome by focusing on phylogenetic evolution, RBD region, deletion mutations in polybasic cleavage site, and primer-template mismatches in the genome. Although the mechanisms responsible for rapid transmission, pathogenicity, and tropism in SARS-CoV-2 remain unclear, identification of mutations in the SARS-CoV-2 genome may help to interpret the high infectivity of the virus with the host.

Materials and Methods
=====================

The set of 4,254 SARS-CoV-2 genome sequences and acknowledgment files were downloaded from the EpiCoV browser (<https://epicov.org/epi3>) of the GISAID \[[@b16-ophrp-2020-11-3-101]\]. The raw data were processed by removing unnecessary genome sequences with low-quality reads, base calling errors, unsolved nucleotides as "N", and small gaps. To investigate the genome-wide phylogenetic analysis, we recombined 12 coding sequences (ORF1a, ORF1b, S, M, E, N, ORF3, ORF6, ORF7a, ORF7b, ORF8, and ORF10), excluding 5′ and 3′ UTR, low-quality sequences, and strains with high sequence similarity within the same clade. As a result of the processing, a reference genome (hCoV-19/Wuhan-Hu-1/2019, EPI_ISL_402125, 29,903 bp) and 178 fully complete genomes were collected. Phylogenetic analysis was performed to identify evolutionary relationships across the genome by using the MEGA \[[@b17-ophrp-2020-11-3-101]\] with parameters such as neighbor joining method, bootstrap 1,000 replications for the phylogeny test, Kimura 2-parameter as a substitution model, and pairwise deletion as gap/missing data treatment. For identifying the types of point mutation (synonymous and non-synonymous mutation) from 4,254 sequences, we separately extracted 12 fully coding sequences (CDSs) determining the sequence of amino acids in a protein from the genomes, and then conducted an in-house program based on Perl computer programming language to analyze mutations among the CDSs and the reference genome. In nomenclature for the replacement from one amino acid to a different amino acid in a gene, we illustrated it as the gene name surrounded by parenthesis after the substitution of amino acids. For example, D614G (S) means that an aspartic acid is converted into a glycine at amino acid position 614 of the S gene in comparison with the reference strain (hCoV-19/Wuhan-Hu-1/2019). For the comparative analysis of primer- and probe-template mismatches, we referred several lists published on the of Centers for Disease Control and Prevention (CDC) websites; <https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-primer-probes.pdf> in CDC Atlanta, <https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf> of the Charité Virology in Germany, <https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16-1-20.pdf> in school of public health at the university of Hong Kong, and <https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf> of the Institut Pasteur in Paris ([Table 1](#t1-ophrp-2020-11-3-101){ref-type="table"}).

Results
=======

1. Phylogenetic analysis of SARS-CoV-2 population
-------------------------------------------------

Phylogenetic analysis was carried out with 178 representative strains to comprehend monophyletic distribution of the SARS-CoV-2 population. The phylogenetic tree showed 3 major clades (S, G, and V clades), similar to previous reports by GISAID. These clades (S, G, and V clades) were determined by the mutations \[L84S (ORF8), G251V (ORF3a), and D614G (S)\], respectively ([Figure 1](#f1-ophrp-2020-11-3-101){ref-type="fig"}). Of the three mutations determining the clades, the significant D614G (S) in G clade is located in the adjacent polybasic cleavage site, but its actual function on RDB/ACE2 affinity is unclear. In addition to the three clades, two subclades belonging G clade were observed and they were named G.1, and G.2 clades referring to their parent clade name. The G.1 and G.2 subclades were determined by three mutations \[G204R (N), R203K (N), and P214L (ORF1b)\], and one mutation \[Q57H (ORF3a)\], respectively ([Figure 2](#f2-ophrp-2020-11-3-101){ref-type="fig"}). In this respect, the derivation of G.1 and G.2 subclades from the G clade shows that a clade can be also determined by one or more mutations.

2. Frequency and types of mutation in SARS-CoV-2 genomes
--------------------------------------------------------

To identify the number and the types of mutation across a total of SARS-CoV-2 strains, the 12 different types of CDS from the 4,254 strains were completely extracted in accordance with the genomic positions presented by the NCBI's GenBank format file (sequence ID: NC_045512.2). The unsuitable sequences with base calling errors, unsolved nucleotides as "N", and undefinable gaps were excluded. A total of 47,176 CDSs were gathered from ORF1a, ORF1b, S, M, E, N, ORF3, ORF6, ORF7a, ORF7b, ORF8, and ORF10. We identified 767 types of synonymous and 1,352 types of non-synonymous mutation from them. Genes with high frequency mutations were ORF1a, ORF1b, S, N, and ORF3a. ORF1a showed the highest frequency mutations containing 302 types of synonymous and 530 types of non-synonymous mutation ([Table 2](#t2-ophrp-2020-11-3-101){ref-type="table"}, [Figure 3](#f3-ophrp-2020-11-3-101){ref-type="fig"}). The non-synonymous mutations with high frequency in the genes were representative mutations in the clades: L84S (ORF8) in S clade, D614G (S) in G clade, G251V (ORF3a) in V clade, P214L (ORF1b), R203K (N) and G204R (N) in G.1 clade, and Q57H (ORF3a) in G.2 clade ([Figures 4](#f4-ophrp-2020-11-3-101){ref-type="fig"} and [5](#f5-ophrp-2020-11-3-101){ref-type="fig"}).

3. Mutations in ORF1a, ORF1b, and RdRp
--------------------------------------

ORF1a and ORF1b encode replicase polyproteins essential component of the viral RNA replication. Therefore, conserved structure of them have been the focus of antiviral drugs \[[@b18-ophrp-2020-11-3-101]\]. RNA-dependent RNA polymerase (RdRp) located between ORF1a and ORF1b is an important component for application and translation and has a functionally conserved region known as high sequence similarity \[[@b19-ophrp-2020-11-3-101]\]. The conserved region of RdRp has been widely used as a target for designing primers and probes based on RT-PCR technology in genetic diagnosis of coronavirus disease 2019 (COVID-19). In this regard, the mutations from ORF1a and ORF1b were analyzed, and we identified 302 types of synonymous and 530 types of non-synonymous mutation in ORF1a, and 179 types of synonymous and 305 types of non-synonymous mutation in ORF1b. Also, a total of 144 types of mutation were identified in the RdRp region corresponding to the 13,442 to 16,236 genomic position, of which 56 types of synonymous and 88 types of non-synonymous mutation were detected ([Figure 6](#f6-ophrp-2020-11-3-101){ref-type="fig"}). Since the non-synonymous mutation with the highest frequency of in the RdRp region was P214L which determines the G.1 subclade together with G204R and R203K of the N gene, it was necessary to further study the functional interaction amongst these mutations of the ORF1a and N gene. On one hand, 9 types of primer-template mismatch were identified in the RdRp region. Although it is not understood how these mismatches affect the stability of primer-template complexes, it is necessary to determine the interrelationships.

4. Mutations in S gene, receptor-binding domain and polybasic cleavage site
---------------------------------------------------------------------------

The S gene of SARS-CoV-2 plays an important role in escaping the immune system of host. The RBD in the S gene is directly or indirectly concerned with the binding and affinity to ACE2. The strong binding between RBD and ACE2 may have led to the worldwide transmission and rapid infectivity of SARS-CoV-2. On the other hand, the RRAR, which is located between S1 and S2 (681--685 amino acid position of the S gene), may be related to the pathogenicity of SARS-CoV-2. Therefore, it is might be inferred from the mutations in the RBD and the polybasic cleavage site in the S gene that the mutations will provide important clues to understanding immunity and pathogenicity of SARS-CoV-2. We identified 109 types of synonymous and 182 types of non-synonymous mutation in the S gene ([Figure 7](#f7-ophrp-2020-11-3-101){ref-type="fig"}). D614G is a major non-synonymous mutation in G clade and accounts for 1,764 (13.0%) in a total of 13,537 non-synonymous mutations. Above all, it is located in the S1--S2 junction region near the polybasic cleavage site, but its biochemical and structural relationships with ACE2 has been unclear so far. In the RBD region (22,478--23,191 genomic position), we found 12 types of synonymous and 27 types of non-synonymous mutation. Among them, the D467V, I468F, I468T, I472V, G476S, S477G, V483A, P491R, Y508H, R509K, and V510L were located within the zone (443--510 amino acid position of the S gene) adjacent to ACE2. In particular, the V483A and G476S mutations have previously been reported to be related to human receptor-binding affinity in MERS and SARS-CoV research \[[@b20-ophrp-2020-11-3-101], [@b21-ophrp-2020-11-3-101]\]. We detected a R682Q mutation from the RRAR, where arginine residue was replaced by glutamine residue. The arginine residue is not only electrically charged but also strongly basic, while the glutamine residue is polar uncharged. Therefore, it is necessary to study how this biochemical difference may affect functional and structural changes of the proteins of S1 or S2. According to a recent study, the fact that a deletion of the QTQTN amino acid motif near the polybasic cleavage site is related to adaptation of SARS-CoV-2 has been reported. Hence, we tried to confirm whether some deletions occurred in this region (675--679 amino acid position of the S gene). We identified no deletion of QTQTN in this region, but confirmed 5 types of non-synonymous mutation (Type 1 with N679Y and S680P, Type 2 with N679K, Type 3 with Q677H, Type 4 with Q675H, and Type 5 with Q675R). Except for Type 1, Type 2 to 5 had a common feature where glutamine and asparagine with a polar uncharged side chain were converted into lysine, histidine, or arginine with basic property. Although deletion of the QTQTN motif was not identified near the polybasic cleavage site, it may be informative to study the functional significance of the five mutations in this region.

5. Mutations in E, M, N and open reading frames encoding accessory proteins
---------------------------------------------------------------------------

The E, M, ORF6, ORF7a, ORF7b, ORF8, and ORF10 are less frequent mutations than other genes. ORF3a is a novel short positive protein essential to viral adaptation *in vitro* and is involved in the viral pathogenicity. The major types of synonymous mutation of ORF3a are Q57H and G251V, which are significant mutations in determining G.2 clade, and V clade, respectively. It is inferred from this result that Q57H and G251V may have a positive effect on viral adaptation. In the E gene known to be involved in viral budding along with the M gene, we confirmed a relatively small number of mutations in it. This means that there are high conserved regions, so it seems reasonable to infer that the preserved sequence is important to encode protein participating in viral reproduction. Like the region of RdRp, the E gene has been also used to design primers and probes for the diagnosis of SARS-CoV-2. We identified 10 types of synonymous and 12 types of non-synonymous mutation in the E gene ([Figure 8](#f8-ophrp-2020-11-3-101){ref-type="fig"}). Of these mutations, 7 primer-template mismatch mutations (3 types of synonymous and 4 types of non-synonymous mutation) occurred. The M gene which is associated with cellular immunogenicity, showed 28 types of synonymous and 21 types of non-synonymous mutation, of which mutations with high frequency were observed as T175M and D3G. Several types of synonymous mutation in ORF6, ORF7, and ORF10 were identified, but mutations with high frequency were not observed. However, L84S in ORF8 was identified as a mutation with high frequency. The N gene packaging of the viral RNA genome into the medical ribonucleocapsid has been regarded as a candidate target region for primers and probes like the E and RdRp genes. In the N gene, we detected 63 types of synonymous and 119 types of non-synonymous mutation. Among them, R203K and G204R showed high frequencies in G.2 clade, together with P214L (ORF1b). In addition, 51 primer-template mismatch mutations (17 types of synonymous and 34 types of non-synonymous mutation) occurred.

Discussion
==========

From the non-synonymous mutation is overall more frequent than the synonymous mutations in the set of 4,254 SARS-CoV-2 genome sequences, it is inferred from this results that the evolution of the SARS-CoV-2 has been accepted to be positive selection. In consequence, several point mutations may directly or indirectly influence the interaction between SARS-CoV-2 and human, and the diversity of mutations in SARS-CoV-2 may enhance the evolution of the virus towards rapid transmission. Based on our analysis, the D614G (S) mutation of G clade, which revealed the highest frequent in our phylogenetic analysis, may have a positive advantage in natural selection. According to the frequency of mutations within SARS-CoV-2 strains, ORF1a, ORF1b, S, and N genes were shown at high frequency, and they may advantageously evolve to adapt to not only external interactions with host cells (such as recognizing a cell surface receptor, attaching to the host receptor, and fusing with cellular membranes), but also internal interactions in host cells (such as replicating and transcribing viral genome, and budding by cellular exocytosis). Although D614G in the S gene is not a mutation within RBD, the fact that it occurred as the highest frequency in all SARS-CoV-2 genomes suggests it may be related to host infection and transmission. Therefore, we believe that it is necessary to continuously monitor the accumulation of mutations and to further study how these mutations affect receptor affinity, propagation ability, and pathogenicity. On the other hand, RdRp, E, and N genes are the target genes for designing primers and probes in RT-PCR-based SARS-CoV-2 diagnosis, owing to their high sequence conservation. It has not been known how the primer-template mismatches affect the accuracy and precision of the genetic diagnosis of COVID-19, but we suggest that it is desirable to avoid the variable hotspot regions as much as possible. Our results about genomic mutations of SARS-CoV-2 strains may be helpful for interpreting the potential relationships of pathogenicity, infectivity, and transmission between SARS-CoV-2 and human host.
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![Phylogenetic tree of SARS-CoV-2. This tree was performed by using the MEGA with parameters such as neighbor joining method, bootstrap 1,000 replications for the phylogeny test, Kimura 2-parameter for substitution model, and pairwise deletion for gap/missing data treatment. S and V clades determined by L84G (ORF8) and G251V (ORF3a), respectively. The reference strain (hCoV-19/Wuhan-Hu-1/2019) is indicated by bold letters on a light gray background. The notation of amino acid substitutions used here means replacements from amino acid of the reference strain on left to a difference amino acid of the corresponding strain on right.\
MEGA = molecular evolutionary genetics analysis.](ophrp-2020-11-3-101f1){#f1-ophrp-2020-11-3-101}

![Phylogenetic tree of G clade and its subclades. G Clade determined by D614G (S) was classified into G.1 clade, G.2 clade, and other strains. G.1 and G.2 clades share Q57H (ORF3a) and G204R (N), R203K (N), together with P214L (ORF1b), respectively. The reference strain (hCoV-19/Wuhan-Hu-1/2019) is indicated by bold letters on a light gray background. The notation of amino acid substitutions used here means replacements from amino acid of the reference strain on left to a difference amino acid of the corresponding strain on right.](ophrp-2020-11-3-101f2){#f2-ophrp-2020-11-3-101}

![Types of mutation distribution in 12 coding sequences. This figure summarizes the distribution of point mutations on 12 coding sequences (ORF1a, ORF1b, S, ORF3a, E, M, ORF6, ORF7a, ORF7b, ORF8, N, and ORF10). Bars filled with red color indicates non-synonymous mutations and bars filled with blue color indicates synonymous mutation. Number above and below bars show the type of mutation.](ophrp-2020-11-3-101f3){#f3-ophrp-2020-11-3-101}

![Frequency of mutations in coding sequences. (A) indicates frequency of 5,940 synonymous mutations (767 types of synonymous mutation) in 47,176 coding sequences from 4,254 strains. (B) indicates frequency of 13,537 non-synonymous mutations (1,352 types of non-synonymous mutation) in them.](ophrp-2020-11-3-101f4){#f4-ophrp-2020-11-3-101}

![Distribution of mutations in SARS-CoV-2 whole genome. The length of SARS-CoV-2 genome is 29,903 bases. SARS-CoV-2 genome is composed of 5′ UTR, ORF1a, ORF1b, S, E, M, N, accessary proteins (ORF3a, ORF6, ORF7, ORF8, and ORF10), and 3′ UTR. The ORF1a and ORF1b encodes from nsp1 to nsp16 proteins.](ophrp-2020-11-3-101f5){#f5-ophrp-2020-11-3-101}

![Distribution of mutations and primer-template mismatches in ORF1a and ORF1b. The genomic positions (13,442--16,236) of RNA-dependent RNA polymerase (RdRp) was based on NCBI ID NC_045512.2. The primer- and probe-template regions were derived from the lists published on the Centers for Disease Control and Prevention (CDC).](ophrp-2020-11-3-101f6){#f6-ophrp-2020-11-3-101}

![Distribution of mutations in receptor-binding domain and polybasic cleavage site within S gene. The genomic positions (22,478--23,191) of receptor-binding domain (RBD) and the amino acid position (682--685) of polybasic cleavage site (PBCS) were based on the reference \[[@b4-ophrp-2020-11-3-101]\], and the reference \[[@b14-ophrp-2020-11-3-101]\], respectivity.](ophrp-2020-11-3-101f7){#f7-ophrp-2020-11-3-101}

![Distribution of mutations and primer-template mismatches in ORF3a, E, M, ORF6, ORF7a, ORF7b, ORF8, N, and ORF10. The genomic positions (13,442--16,236) of RNA-dependent RNA polymerase (RdRp) was based on NCBI ID NC_045512.2. The primer- and probe-template regions were retrieved from the lists published on the Centers for Disease Control and Prevention (CDC).](ophrp-2020-11-3-101f8){#f8-ophrp-2020-11-3-101}

###### 

Primers and probes for the detection of SARS-CoV-2 of global research institutions.

  Target gene   Type of oligonucleotide                 Sequence (5′-\>3′)           Source
  ------------- --------------------------------------- ---------------------------- ------------------
  ORF1a         Forward                                 ATGAGCTTAGTCCTGTTG           France (Pasteur)
  Probe         HEX-AGATGTCTTGTGCTGCCGGTA-BHQ1          France (Pasteur)             
  Reverse       CTCCCTTTGTTGTGTTGT                      France (Pasteur)             
  Forward       CCCTGTGGGTTTTACACTTAA                   China (CDC)                  
  Probe         FAM-CCGTCTGCGGTATGTGGAAAGGTTATGG-BHQ1   China (CDC)                  
  Reverse       ACGATTGTGCATCAGCTGA                     China (CDC)                  
                                                                                     
  RdRp          Forward                                 GGTAACTGGTATGATTTCG          France (Pasteur)
  Probe         FAM-TCATACAAACCACGCCAGG-BHQ1            France (Pasteur)             
  Reverse       CTGGTCAAGGTTAATATAGG                    France (Pasteur)             
  Forward       GTGARATGGTCATGTGTGGCGG                  Germany (Charité)            
  Probe         FAM-CCAGGTGGWACRTCATCMGGTGATGC-BBQ      Germany (Charité)            
  Probe         FAM-CAGGTGGAACCTCATCAGGAGATGC-BBQ       Germany (Charité)            
  Reverse       CARATGTTAAASACACTATTAGCATA              Germany (Charité)            
                                                                                     
  ORF1b         Forward                                 TGGGGYTTTACRGGTAACCT         China (HKU)
  Probe         FAM-TAGTTGTGATGCWATCATGACTAG-TAMRA      China (HKU)                  
  Reverse       AACRCGCTTAACAAAGCACTC                   China (HKU)                  
                                                                                     
  E             Forward                                 ACAGGTACGTTAATAGTTAATAGCGT   France (Pasteur)
  Forward       ACAGGTACGTTAATAGTTAATAGCGT              Germany (Charité)            
  Probe         FAM-ACACTAGCCATCCTTACTGCGCTTCG-BHQ1     France (Pasteur)             
  Reverse       ATATTGCAGCAGTACGCACACA                  Germany (Charité)            
  Probe         FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ      Germany (Charité)            
  Reverse       ATATTGCAGCAGTACGCACACA                  France (Pasteur)             
                                                                                     
  N             Forward                                 GACCCCAAAATCAGCGAAAT         US (CDC)
  Probe         FAM-ACCCCGCATTACGTTTGGTGGACC-BHQ1       US (CDC)                     
  Reverse       TCTGGTTACTGCCAGTTGAATCTG                US (CDC)                     
  Forward       GGGAGCCTTGAATACACCAAAA                  US (CDC)                     
  Probe         FAM-AYCACATTGGCACCCGCAATCCTG-BHQ1       US (CDC)                     
  Reverse       TGTAGCACGATTGCAGCATTG                   US (CDC)                     
  Forward       GGGGAACTTCTCCTGCTAGAAT                  China (CDC)                  
  Probe         FAM-TTGCTGCTGCTTGACAGATT-TAMRA          China (CDC)                  
  Reverse       CAGACATTTTGCTCTCAAGCTG                  China (CDC)                  
  Forward       TAATCAGACAAGGAACTGATTA                  China (HKU)                  
  Forward       TTACAAACATTGGCCGCAAA                    US (CDC)                     
  Probe         FAM-GCAAATTGTGCAATTTGCGG-TAMRA          China (HKU)                  
  Probe         FAM-ACAATTTGCCCCCAGCGCTTCAG-BHQ1        US (CDC)                     
  Reverse       GCGCGACATTCCGAAGAA                      US (CDC)                     
  Reverse       CGAAGGTGTGACTTCCATG                     China (HKU)                  

This table was based on primer and probe provided by the World Health Organization (WHO).

###### 

Frequency of point mutations by 12 coding sequences.

  CDS     Genomic position[\*](#tfn3-ophrp-2020-11-3-101){ref-type="table-fn"}   Point mutations                         
  ------- ---------------------------------------------------------------------- ----------------- ------- ------- ----- -----
  ORF1a   3,325                                                                  266--13,483       3,199   2,850   302   530
                                                                                                                         
  ORF1b   3,360                                                                  13,768--21,555    1,700   3,194   179   305
                                                                                                                         
  S       3,498                                                                  21,563--25,384    367     2,212   109   182
                                                                                                                         
  ORF3a   4,116                                                                  25,393--26,220    72      1,450   36    78
                                                                                                                         
  E       4,216                                                                  26,245--26,472    23      21      10    12
                                                                                                                         
  M       4,101                                                                  26,523--27,191    147     251     28    21
                                                                                                                         
  ORF6    4,199                                                                  27,202--27,387    29      34      6     19
                                                                                                                         
  ORF7a   3,965                                                                  27,394--27,759    35      71      13    35
                                                                                                                         
  ORF7b   3,988                                                                  27,756--27,887    8       9       5     8
                                                                                                                         
  ORF8    4,198                                                                  27,894--28,259    26      874     12    32
                                                                                                                         
  N       4,080                                                                  28,274--29,533    305     2,549   63    119
                                                                                                                         
  ORF10   4,130                                                                  29,558--29,674    29      22      4     11

CDS = coding sequence.

Genomic position was referred to a reference strain (hCoV-19/Wuhan-Hu-1/2019, EPI_ISL_402125).
